China Health Group Limited (HKG:0673)

China Health Group Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	21.44	1.05	4.01	11.48	8.54
Short-Term Investments	4.39	4.51	-	6.25	0.5
Cash & Short-Term Investments	25.83	5.56	4.01	17.73	9.04
Cash Growth	364.37%	38.60%	-77.36%	96.16%	78.92%
Accounts Receivable	21.06	21.23	30.04	30.75	38.16
Other Receivables	33.62	34.78	-	6.97	12.6
Receivables	79.32	90.36	76.29	96.94	110.62
Inventory	11.45	13.54	18.6	11.67	13.43
Prepaid Expenses	2.45	5.09	30.09	15.8	4.61
Restricted Cash	0.51	0.07	-	-	-
Total Current Assets	119.56	114.62	128.98	142.14	137.7
Property, Plant & Equipment	16.53	17.42	18.27	21.78	26.07
Goodwill	9.66	13.56	25.63	37.88	40.97
Other Intangible Assets	1.95	1.75	2.91	2.26	2.69
Other Long-Term Assets	9.86	-	16.52	17.13	18.53
Total Assets	157.56	147.35	192.32	221.19	225.96

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	30.48	24.39	31.55	24.12	21.14
Accrued Expenses	21.39	21.03	27.47	22.61	24.03
Short-Term Debt	4.28	5.42	5.51	5.68	17.62
Current Portion of Leases	0.31	0.66	0.15	0.35	0.85
Current Income Taxes Payable	-	0.53	0.49	1.65	3.91
Current Unearned Revenue	0.66	3.92	5.11	5.47	1.4
Other Current Liabilities	39.6	76.02	41.84	67.35	67.95
Total Current Liabilities	96.71	131.97	112.11	127.24	136.9
Long-Term Leases	-	0.43	-	-	-
Long-Term Deferred Tax Liabilities	-	-	0.13	-	-
Other Long-Term Liabilities	-	14.86	20.33	-	3.93
Total Liabilities	96.71	147.25	132.56	127.24	140.83

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	138.71	49.16	47.9	471.8	414
Additional Paid-In Capital	91.09	73.97	65.33	585.46	583.08
Retained Earnings	-161.49	-113.56	-45.77	-958.53	-916.59
Comprehensive Income & Other	-15.04	-17.25	-15.43	-12.39	-0.91
Total Common Equity	53.28	-7.66	52.04	86.33	79.58
Minority Interest	7.57	7.76	7.72	7.62	5.55
Shareholders' Equity	60.84	0.1	59.75	93.95	85.13
Total Liabilities & Equity	157.56	147.35	192.32	221.19	225.96

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	4.59	6.5	5.66	6.04	18.47
Net Cash (Debt)	21.24	-0.94	-1.64	11.69	-9.43
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	0.02	-0.00	-0.00	0.03	-0.02
Filing Date Shares Outstanding	1,387	491.64	478.99	471.79	413.99
Total Common Shares Outstanding	1,387	491.64	478.99	471.79	413.99
Working Capital	22.84	-17.35	16.88	14.9	0.81
Book Value Per Share	0.04	-0.02	0.11	0.18	0.19
Tangible Book Value	41.66	-22.97	23.5	46.19	35.92
Tangible Book Value Per Share	0.03	-0.05	0.05	0.10	0.09
Buildings	14.39	13.77	14	14.52	15.7
Machinery	12.25	12.33	11.22	11.67	12.89
Leasehold Improvements	6.66	6.34	6.21	6.15	6.38

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error